Quiddity Leaderboard CSI Medical Dec26: Expectations Have Changed; US$301mn One-Way
There are three index members failing the liquidity test by narrow margins and they should be monitored until the end of the reference period.
36 Views
Primer: Shandong Weigao Blood Purification Products (603014 CH) - Apr 2026
Leading Domestic Player in a High-Growth Market: Shandong Weigao Blood Purification Products is a dominant force in China's rapidly expanding...
94 Views
Quiddity Leaderboard CSI Medical Dec26: Expected ADDs Are Underperforming Expected DELs
The current expected ADDs have underperformed the current expected DELs in the last month. This is another example of the negative momentum in some...
181 Views
Quiddity Leaderboard CSI Medical Dec26: 6 ADDs/DELs Expected; US$236mn One-Way Flows
Most expected ADDs/DELs have between 1x-4x ADV to trade and flow sizes of US$25mn-US$45mn. Beijing Wantai Bio (603392 CH) is the most significant...
177 Views
Quiddity Leaderboard CSI Medical Jun26: Final Expectations
We estimate the CSI Medical June 2026 index rebalance to trigger one-way flow of ~US$319mn. The results could be announced on 29th May 2026.
255 Views